Reproductive  ||| S:0 E:13 ||| JJ
factors  ||| S:13 E:21 ||| NNS
and  ||| S:21 E:25 ||| CC
breast  ||| S:25 E:32 ||| JJ
cancer ||| S:32 E:38 ||| NN
:  ||| S:38 E:40 ||| :
principal  ||| S:40 E:50 ||| JJ
findings  ||| S:50 E:59 ||| NNS
in  ||| S:59 E:62 ||| IN
Latin  ||| S:62 E:68 ||| NNP
America  ||| S:68 E:76 ||| NNP
and  ||| S:76 E:80 ||| CC
the  ||| S:80 E:84 ||| DT
world  ||| S:84 E:90 ||| NN
Early  ||| S:90 E:96 ||| RB
age  ||| S:96 E:100 ||| NN
at  ||| S:100 E:103 ||| IN
menarche  ||| S:103 E:112 ||| NN
and  ||| S:112 E:116 ||| CC
late  ||| S:116 E:121 ||| JJ
age  ||| S:121 E:125 ||| NN
at  ||| S:125 E:128 ||| IN
menopause ||| S:128 E:137 ||| NN
,  ||| S:137 E:139 ||| ,
nulliparity ||| S:139 E:150 ||| NN
,  ||| S:150 E:152 ||| ,
and  ||| S:152 E:156 ||| CC
late  ||| S:156 E:161 ||| JJ
age  ||| S:161 E:165 ||| NN
at  ||| S:165 E:168 ||| IN
first  ||| S:168 E:174 ||| JJ
pregnancy  ||| S:174 E:184 ||| NN
have  ||| S:184 E:189 ||| VBP
been  ||| S:189 E:194 ||| VBN
associated  ||| S:194 E:205 ||| VBN
with  ||| S:205 E:210 ||| IN
an  ||| S:210 E:213 ||| DT
increased  ||| S:213 E:223 ||| JJ
risk  ||| S:223 E:228 ||| NN
of  ||| S:228 E:231 ||| IN
BC ||| S:231 E:233 ||| NNP
.  ||| S:233 E:235 ||| .
In  ||| S:235 E:238 ||| IN
contrast ||| S:238 E:246 ||| NN
,  ||| S:246 E:248 ||| ,
parity  ||| S:248 E:255 ||| NN
and  ||| S:255 E:259 ||| CC
the  ||| S:259 E:263 ||| DT
increase  ||| S:263 E:272 ||| NN
in  ||| S:272 E:275 ||| IN
time  ||| S:275 E:280 ||| NN
breastfeeding ||| S:280 E:293 ||| NN
,  ||| S:293 E:295 ||| ,
particularly  ||| S:295 E:308 ||| RB
during  ||| S:308 E:315 ||| IN
the  ||| S:315 E:319 ||| DT
first  ||| S:319 E:325 ||| JJ
child  ||| S:325 E:331 ||| NN
have  ||| S:331 E:336 ||| VBP
been  ||| S:336 E:341 ||| VBN
associated  ||| S:341 E:352 ||| VBN
with  ||| S:352 E:357 ||| IN
a  ||| S:357 E:359 ||| DT
decreased  ||| S:359 E:369 ||| JJ
risk ||| S:369 E:373 ||| NN
.  ||| S:373 E:375 ||| .
The  ||| S:375 E:379 ||| DT
hypothesis  ||| S:379 E:390 ||| NN
that  ||| S:390 E:395 ||| IN
ovarian  ||| S:395 E:403 ||| JJ
function ||| S:403 E:411 ||| NN
,  ||| S:411 E:413 ||| ,
through  ||| S:413 E:421 ||| IN
their  ||| S:421 E:427 ||| PRP$
hormones ||| S:427 E:435 ||| NNS
,  ||| S:435 E:437 ||| ,
plays  ||| S:437 E:443 ||| VBZ
an  ||| S:443 E:446 ||| DT
important  ||| S:446 E:456 ||| JJ
role  ||| S:456 E:461 ||| NN
in  ||| S:461 E:464 ||| IN
the  ||| S:464 E:468 ||| DT
etiology  ||| S:468 E:477 ||| NN
of  ||| S:477 E:480 ||| IN
breast  ||| S:480 E:487 ||| JJ
cancer  ||| S:487 E:494 ||| NN
has  ||| S:494 E:498 ||| VBZ
been  ||| S:498 E:503 ||| VBN
supported  ||| S:503 E:513 ||| VBN
by  ||| S:513 E:516 ||| IN
various  ||| S:516 E:524 ||| JJ
studies  ||| S:524 E:532 ||| NNS
for  ||| S:532 E:536 ||| IN
a  ||| S:536 E:538 ||| DT
long  ||| S:538 E:543 ||| JJ
time ||| S:543 E:547 ||| NN
.  ||| S:547 E:549 ||| .
Although  ||| S:549 E:558 ||| IN
most  ||| S:558 E:563 ||| JJS
of  ||| S:563 E:566 ||| IN
the  ||| S:566 E:570 ||| DT
risk  ||| S:570 E:575 ||| NN
factors  ||| S:575 E:583 ||| NNS
associated  ||| S:583 E:594 ||| VBN
with  ||| S:594 E:599 ||| IN
reproductive  ||| S:599 E:612 ||| JJ
characteristics  ||| S:612 E:628 ||| NNS
are  ||| S:628 E:632 ||| VBP
difficult  ||| S:632 E:642 ||| JJ
to  ||| S:642 E:645 ||| TO
modify ||| S:645 E:651 ||| VB
,  ||| S:651 E:653 ||| ,
to  ||| S:653 E:656 ||| TO
increase  ||| S:656 E:665 ||| VB
the  ||| S:665 E:669 ||| DT
breastfeeding  ||| S:669 E:683 ||| JJ
time  ||| S:683 E:688 ||| NN
and  ||| S:688 E:692 ||| CC
to  ||| S:692 E:695 ||| TO
avoid  ||| S:695 E:701 ||| VB
exposure  ||| S:701 E:710 ||| NN
to  ||| S:710 E:713 ||| TO
known  ||| S:713 E:719 ||| JJ
carcinogens  ||| S:719 E:731 ||| NN
during  ||| S:731 E:738 ||| IN
periods  ||| S:738 E:746 ||| NNS
of  ||| S:746 E:749 ||| IN
development  ||| S:749 E:761 ||| NN
of  ||| S:761 E:764 ||| IN
the  ||| S:764 E:768 ||| DT
mammary  ||| S:768 E:776 ||| JJ
gland  ||| S:776 E:782 ||| NNS
are  ||| S:782 E:786 ||| VBP
good  ||| S:786 E:791 ||| JJ
strategies  ||| S:791 E:802 ||| NNS
to  ||| S:802 E:805 ||| TO
reduce  ||| S:805 E:812 ||| VB
the  ||| S:812 E:816 ||| DT
risk  ||| S:816 E:821 ||| NN
of  ||| S:821 E:824 ||| IN
this  ||| S:824 E:829 ||| DT
disease ||| S:829 E:836 ||| NN
.  ||| S:836 E:838 ||| .
